TapewireFind a company

person · Reporting owner

LAVIZZO-MOUREY RISA J

Disclosed activity across 6 companies

Tapewire entity
10743
SEC CIK
0001034465

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Better Therapeutics, Inc.BTTX · Entity 94385DirectorDecember 18, 2023December 20, 2023
GE HealthCare Technologies Inc.GEHC · Entity 1711DirectorMay 28, 2025May 30, 2025
GENERAL ELECTRIC COGE · Entity 2813DirectorJanuary 03, 2023January 05, 2023
HESS CORPHES · Entity 11019DirectorMarch 06, 2020March 10, 2020
INTEL CORPINTC · Entity 2799DirectorMay 08, 2024May 10, 2024
Merck & Co., Inc.MRK · Entity 2807DirectorMay 29, 2026June 02, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Better Therapeutics, Inc.

Report date December 18, 2023 · Filed December 20, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect13,750 Reported balance After 2023-12-18 transaction · row 1
1 source row

Row 1 · 2023-12-18 · Grant · Acquired 3,750 · Balance 13,750

F1: The Reporting person was awarded 3,750 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024.

Filing footnotes · ownership attribution and instrument terms

F1: The Reporting person was awarded 3,750 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024.

GE HealthCare Technologies Inc.

Report date May 28, 2025 · Filed May 30, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, par value $0.01 per shareSEC Table I · non-derivativeDirect10,157 Reported balance After 2025-05-28 transaction · row 1
1 source row

Row 1 · 2025-05-28 · Grant · Acquired 3,092 · Balance 10,157

F1: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Filing footnotes · ownership attribution and instrument terms

F1: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

GENERAL ELECTRIC CO

Report date January 03, 2023 · Filed January 05, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Deferred Fee Phantom Stock UnitsSEC Table II · derivative / convertible securityDirect13,252 Reported balance After 2023-01-03 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2023-01-03 · Grant · Acquired 519 · Balance 13,252

F1: Acquired at a price of $82.41 per unit pursuant to the terms of the 2022 Long-Term Incentive Plan.

F2: Each unit of phantom stock is the economic equivalent of one share of the issuer's common stock.

F3: Payable beginning one year after termination of service as a director.

Filing footnotes · ownership attribution and instrument terms

F1: Acquired at a price of $82.41 per unit pursuant to the terms of the 2022 Long-Term Incentive Plan.

F2: Each unit of phantom stock is the economic equivalent of one share of the issuer's common stock.

F3: Payable beginning one year after termination of service as a director.

HESS CORP

Report date March 06, 2020 · Filed March 10, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, $1.00 par valueSEC Table I · non-derivativeDirect44,379 Reported balance After 2020-03-06 transaction · row 1
1 source row

Row 1 · 2020-03-06 · Grant · Acquired 1,491 · Balance 44,379

INTEL CORP

Report date May 08, 2024 · Filed May 10, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect7,403 Reported balance After 2024-05-08 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2024-05-08 · Grant · Acquired 7,403 · Balance 7,403

F1: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.

F2: The reporting person elected to defer settlement of their grant of restricted stock units until the termination of their service to the Intel Corporation Board of Directors.

F3: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2025 Annual Stockholders' Meeting.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.

F2: The reporting person elected to defer settlement of their grant of restricted stock units until the termination of their service to the Intel Corporation Board of Directors.

F3: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2025 Annual Stockholders' Meeting.

Merck & Co., Inc.

Report date May 29, 2026 · Filed June 02, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom StockSEC Table II · derivative / convertible securityDirect17,749.3517 Reported balance After 2026-05-29 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-05-29 · Grant · Acquired 1,853.0997 · Balance 17,749.3517

F1: 1-for-1

F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3: Holdings include shares acquired in dividend reinvestment transactions.

Common StockSEC Table I · non-derivativeDirect1,000 Reported balance Holding disclosure · report date 2026-05-29 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 1,000

Filing footnotes · ownership attribution and instrument terms

F1: 1-for-1

F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3: Holdings include shares acquired in dividend reinvestment transactions.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 29, 2026 Filed Jun 2, 2026 18:09 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 1,853.0997 $118.72 $220,000.00
Disclosure

SEC source: 0000310158-26-000153 · form4.xml · derivative · entry 2

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,749.3517

Underlying: Common Stock · 1,853.0997 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 30, 2025 Filed Jun 3, 2025 17:05 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 2,863.0921 $76.84 $220,000.00
Disclosure

SEC source: 0001127602-25-016354 · form4.xml · derivative · entry 2

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,367.349

Underlying: Common Stock · 2,863.0921 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:05 UTC GE HealthCare Technologies Inc. GEHC · Entity 1711 GrantCommon Stock, par value $0.01 per share 3,092 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-028703 · wk-form4_1748642692.xml · nonDerivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,157

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 18:15 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 1,752.4295 $125.54 $220,000.00
Disclosure

SEC source: 0001127602-24-017571 · form4.xml · derivative · entry 2

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,120.4279

Underlying: Common Stock · 1,752.4295 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:32 UTC GE HealthCare Technologies Inc. GEHC · Entity 1711 GrantCommon Stock, par value $0.01 per share 2,440 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-024965 · wk-form4_1716496324.xml · nonDerivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,065

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:18 UTC INTEL CORP INTC · Entity 2799 GrantRestricted Stock Units · Derivative 7,403 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-014994 · form4.xml · derivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,403

Underlying: Common Stock · 7,403 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.

F2 · derivative.exercise_date: The reporting person elected to defer settlement of their grant of restricted stock units until the termination of their service to the Intel Corporation Board of Directors.

F3 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2025 Annual Stockholders' Meeting.

F2 · derivative.expiration_date: The reporting person elected to defer settlement of their grant of restricted stock units until the termination of their service to the Intel Corporation Board of Directors.

F3 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2025 Annual Stockholders' Meeting.

Read SEC document
May 07, 2024 Filed May 9, 2024 20:16 UTC INTEL CORP INTC · Entity 2799 Exercise / conversionRestricted Stock Units · Derivative 7,152 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-014789 · form4.xml · derivative · entry 2

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,152 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.

F2 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2024 Annual Stockholders' Meeting.

F2 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2024 Annual Stockholders' Meeting.

Read SEC document
May 07, 2024 Filed May 9, 2024 20:16 UTC INTEL CORP INTC · Entity 2799 Exercise / conversionCommon Stock 7,152 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-014789 · form4.xml · nonDerivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,772

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.

Read SEC document
December 18, 2023 Filed Dec 20, 2023 22:23 UTC Better Therapeutics, Inc. BTTX · Entity 94385 GrantCommon Stock 3,750 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-071960 · ownership.xml · nonDerivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,750

F1 · shares: The Reporting person was awarded 3,750 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 22:55 UTC Better Therapeutics, Inc. BTTX · Entity 94385 GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $0.77 $0.00
Disclosure

SEC source: 0000950170-23-027335 · ownership.xml · derivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2033-06-06

F1 · derivative.exercise_date: The stock option vests in full on the earlier of the first anniversary of the grant date and the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director of the Issuer on such vesting date. The stock option was granted on June 7, 2023.

Read SEC document
May 26, 2023 Filed May 31, 2023 20:20 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 1,980.7329 $111.07 $220,000.00
Disclosure

SEC source: 0001127602-23-017227 · form4.xml · derivative · entry 2

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,100.3274

Underlying: Common Stock · 1,980.7329 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

Read SEC document
May 23, 2023 Filed May 25, 2023 20:29 UTC GE HealthCare Technologies Inc. GEHC · Entity 1711 GrantCommon Stock, par value $0.01 per share 3,584 $0.00 $0.00
Disclosure

SEC source: 0001628280-23-019777 · wf-form4_168504654928723.xml · nonDerivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,625

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 23, 2024. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 11, 2023 Filed May 15, 2023 23:11 UTC INTEL CORP INTC · Entity 2799 Exercise / conversionRestricted Stock Units · Derivative 4,828 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-23-015630 · form4.xml · derivative · entry 3

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,828 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.

F3 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of May 12, 2023 or the date of the 2023 Annual Stockholders' Meeting.

F3 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of May 12, 2023 or the date of the 2023 Annual Stockholders' Meeting.

Read SEC document
May 11, 2023 Filed May 15, 2023 23:11 UTC INTEL CORP INTC · Entity 2799 GrantRestricted Stock Units · Derivative 7,152 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-23-015630 · form4.xml · derivative · entry 2

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,152

Underlying: Common Stock · 7,152 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.

F2 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2024 Annual Stockholders' Meeting.

F2 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2024 Annual Stockholders' Meeting.

Read SEC document
May 11, 2023 Filed May 15, 2023 23:11 UTC INTEL CORP INTC · Entity 2799 Exercise / conversionCommon Stock 4,828 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-23-015630 · form4.xml · nonDerivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,620

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 01:52 UTC GE HealthCare Technologies Inc. GEHC · Entity 1711 GrantDeferred Fee Phantom Stock Units · Derivative 4,417 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-23-001119 · doc4.xml · derivative · entry 2

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,417

Underlying: Common stock, par value $0.01 per share · 4,417 shares

Expires not disclosed

F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock of GE HealthCare.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F3 · derivative.exercise_date: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F3 · derivative.expiration_date: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F3 · balance_after: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 01:52 UTC GE HealthCare Technologies Inc. GEHC · Entity 1711 GrantCommon stock, par value $0.01 per share 1,041 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-23-001119 · doc4.xml · nonDerivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,041

F1 · shares: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F1 · balance_after: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 22:10 UTC GENERAL ELECTRIC CO GE · Entity 2813 GrantDeferred Fee Phantom Stock Units · Derivative 519 $82.41 $42,770.79
Disclosure

SEC source: 0000040545-23-000008 · wf-form4_167295660735163.xml · derivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,252

Underlying: Common Stock · 519 shares

Expires not disclosed

F1 · security: Acquired at a price of $82.41 per unit pursuant to the terms of the 2022 Long-Term Incentive Plan.

F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of the issuer's common stock.

F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director.

F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director.

Read SEC document
October 01, 2022 Filed Oct 4, 2022 21:06 UTC GENERAL ELECTRIC CO GE · Entity 2813 GrantDeferred Fee Phantom Stock Units · Derivative 627 $68.21 $42,767.67
Disclosure

SEC source: 0001062993-22-020363 · form4.xml · derivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,720

Underlying: Common Stock · 627 shares

Expires not disclosed

F1 · security: Acquired at a price of $68.21 per unit pursuant to the terms of the 2022 Long-Term Incentive Plan.

F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock.

F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director.

F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 21:06 UTC GENERAL ELECTRIC CO GE · Entity 2813 GrantDeferred Fee Phantom Stock Units · Derivative 615 $69.53 $42,760.95
Disclosure

SEC source: 0001062993-22-016087 · form4.xml · derivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,080

Underlying: Common Stock · 615 shares

Expires not disclosed

F1 · security: Acquired at a price of $69.53 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan.

F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock.

F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director.

F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director.

Read SEC document
June 09, 2022 Filed Jun 10, 2022 20:40 UTC Better Therapeutics, Inc. BTTX · Entity 94385 GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $1.66 $0.00
Disclosure

SEC source: 0000899243-22-021936 · doc4.xml · derivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2032-06-08

F1 · derivative.exercise_date: The stock option vests in full on the earlier of the first anniversary of the grant date and the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director of the Issuer on such vesting date. The stock option was granted on June 9, 2022.

Read SEC document
May 27, 2022 Filed Jun 1, 2022 20:17 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 2,363.5582 $93.08 $220,000.00
Disclosure

SEC source: 0001127602-22-016158 · form4.xml · derivative · entry 2

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,892.9615

Underlying: Common Stock · 2,363.5582 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 12, 2022 Filed May 16, 2022 23:28 UTC INTEL CORP INTC · Entity 2799 Exercise / conversionRestricted Stock Units · Derivative 3,720 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-22-014677 · form4.xml · derivative · entry 3

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,720 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.

F3 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2022 Annual Stockholders' Meeting.

F3 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2022 Annual Stockholders' Meeting.

Read SEC document
May 12, 2022 Filed May 16, 2022 23:28 UTC INTEL CORP INTC · Entity 2799 GrantRestricted Stock Units · Derivative 4,828 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-22-014677 · form4.xml · derivative · entry 2

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,828

Underlying: Common Stock · 4,828 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.

F2 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of May 12, 2023 or the date of the 2023 Annual Stockholders' Meeting.

F2 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of May 12, 2023 or the date of the 2023 Annual Stockholders' Meeting.

Read SEC document
May 12, 2022 Filed May 16, 2022 23:28 UTC INTEL CORP INTC · Entity 2799 Exercise / conversionCommon Stock 3,720 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-22-014677 · form4.xml · nonDerivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,792

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.

Read SEC document
April 01, 2022 Filed Apr 4, 2022 21:04 UTC GENERAL ELECTRIC CO GE · Entity 2813 GrantDeferred Fee Phantom Stock Units · Derivative 462 $92.62 $42,790.44
Disclosure

SEC source: 0001062993-22-009491 · form4.xml · derivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,455

Underlying: Common Stock · 462 shares

Expires not disclosed

F1 · security: Acquired at a price of $92.62 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan.

F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock.

F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director.

F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director.

Read SEC document
January 30, 2022 Filed Feb 2, 2022 00:16 UTC INTEL CORP INTC · Entity 2799 Exercise / conversionRestricted Stock Units · Derivative 1,993 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-22-002837 · form4.xml · derivative · entry 2

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,993 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the "Company") common stock.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the "Company") common stock.

F2 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the anniversary of the grant date (or next business date, if applicable).

F2 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the anniversary of the grant date (or next business date, if applicable).

Read SEC document
January 30, 2022 Filed Feb 2, 2022 00:16 UTC INTEL CORP INTC · Entity 2799 Exercise / conversionCommon Stock 1,993 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-22-002837 · form4.xml · nonDerivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,072

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the "Company") common stock.

Read SEC document
January 03, 2022 Filed Jan 4, 2022 22:44 UTC GENERAL ELECTRIC CO GE · Entity 2813 GrantDeferred Fee Phantom Stock Units · Derivative 454 $94.23 $42,780.42
Disclosure

SEC source: 0001062993-22-000345 · form4.xml · derivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,984

Underlying: Common Stock · 454 shares

Expires not disclosed

F1 · security: Acquired at a price of $94.23 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director.

F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock.

F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director.

F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director.

Read SEC document
December 21, 2021 Filed Dec 23, 2021 23:20 UTC Better Therapeutics, Inc. BTTX · Entity 94385 PurchaseCommon Stock 10,000 $4.60 $46,000.00
Disclosure

SEC source: 0000899243-21-049671 · doc4.xml · nonDerivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Read SEC document
October 28, 2021 Filed Nov 2, 2021 00:55 UTC Better Therapeutics, Inc. BTTX · Entity 94385 GrantStock Option (Right to Buy) · Derivative 28,300 $0.00 Strike: $10.97 $0.00
Disclosure

SEC source: 0000899243-21-042249 · doc4.xml · derivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,300

Underlying: Common Stock · 28,300 shares

Expires 2031-10-27

F1 · derivative.exercise_date: Following the Issuer's filing of Form S-8 to register the shares subject to the stock option, the stock option vests as to 1/3 of the shares subject to the stock option on October 28, 2022 and the remaining shares vest in 24 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on October 28, 2021.

Read SEC document
October 25, 2021 Filed Oct 26, 2021 20:07 UTC INTEL CORP INTC · Entity 2799 PurchaseCommon Stock 5,000 $49.50 $247,500.00
Disclosure

SEC source: 0001127602-21-027641 · form4.xml · nonDerivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,079

Read SEC document
October 01, 2021 Filed Oct 1, 2021 20:50 UTC GENERAL ELECTRIC CO GE · Entity 2813 GrantDeferred Fee Phantom Stock Units · Derivative 416 $102.67 $42,710.72
Disclosure

SEC source: 0001062993-21-009080 · form4.xml · derivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,523

Underlying: Common Stock · 416 shares

Expires not disclosed

F1 · security: Acquired at a price of $102.67 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director.

F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock.

F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director.

F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director.

F4 · balance_after: Reflects adjustments made in connection with the 1-for-8 reverse stock split of the Issuer's common stock.

Read SEC document
July 01, 2021 Filed Jul 1, 2021 20:49 UTC GENERAL ELECTRIC CO GE · Entity 2813 GrantDeferred Fee Phantom Stock Units · Derivative 3,190 $13.40 $42,746.00
Disclosure

SEC source: 0001062993-21-006167 · form4.xml · derivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,792

Underlying: Common Stock · 3,190 shares

Expires not disclosed

F1 · security: Acquired at a price of $13.40 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director.

F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock.

F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director.

F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director.

Read SEC document
May 28, 2021 Filed Jun 2, 2021 17:50 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 2,635.3933 $75.89 $200,000.00
Disclosure

SEC source: 0001127602-21-018656 · form4.xml · derivative · entry 2

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,192.6703

Underlying: Common Stock · 2,635.3933 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 13, 2021 Filed May 17, 2021 20:45 UTC INTEL CORP INTC · Entity 2799 GrantRestricted Stock Units · Derivative 3,720 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-017050 · form4.xml · derivative · entry 3

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,720

Underlying: Common Stock · 3,720 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the "Company") common stock.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the "Company") common stock.

F3 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2022 Annual Stockholders' Meeting.

F3 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2022 Annual Stockholders' Meeting.

Read SEC document
May 13, 2021 Filed May 17, 2021 20:45 UTC INTEL CORP INTC · Entity 2799 Exercise / conversionRestricted Stock Units · Derivative 3,721 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-017050 · form4.xml · derivative · entry 2

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,721 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the "Company") common stock.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the "Company") common stock.

F2 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2021 Annual Stockholders' Meeting.

F2 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2021 Annual Stockholders' Meeting.

Read SEC document
May 13, 2021 Filed May 17, 2021 20:45 UTC INTEL CORP INTC · Entity 2799 Exercise / conversionCommon Stock 3,721 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-017050 · form4.xml · nonDerivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,079

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the "Company") common stock.

Read SEC document
April 01, 2021 Filed Apr 2, 2021 00:06 UTC GENERAL ELECTRIC CO GE · Entity 2813 GrantDeferred Fee Phantom Stock Units · Derivative 3,244 $13.18 $42,755.92
Disclosure

SEC source: 0001231205-21-000120 · edgar.xml · derivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,547

Underlying: Common Stock · 3,244 shares

Expires not disclosed

F1 · security: Acquired at a price of $13.18 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director.

F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock.

F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director.

F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director.

Read SEC document
February 01, 2021 Filed Feb 3, 2021 01:58 UTC INTEL CORP INTC · Entity 2799 Exercise / conversionRestricted Stock Units · Derivative 593 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-003591 · form4.xml · derivative · entry 5

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 593 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock.

F3 · derivative.exercise_date: Unless earlier forfeited under the terms of the RSU, 33 1/3% of the awards vest and convert into common stock on each anniversary of January 30, 2018, unless that date falls on a non-business date, in which case the next business date shall apply.

F3 · derivative.expiration_date: Unless earlier forfeited under the terms of the RSU, 33 1/3% of the awards vest and convert into common stock on each anniversary of January 30, 2018, unless that date falls on a non-business date, in which case the next business date shall apply.

Read SEC document
February 01, 2021 Filed Feb 3, 2021 01:58 UTC INTEL CORP INTC · Entity 2799 Exercise / conversionRestricted Stock Units · Derivative 1,580 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-003591 · form4.xml · derivative · entry 4

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,580 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock.

F2 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the anniversary of the grant date (or next business date, if applicable).

F2 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the anniversary of the grant date (or next business date, if applicable).

Read SEC document
February 01, 2021 Filed Feb 3, 2021 01:58 UTC INTEL CORP INTC · Entity 2799 Exercise / conversionCommon Stock 593 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-003591 · form4.xml · nonDerivative · entry 2

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,358

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock.

Read SEC document
February 01, 2021 Filed Feb 3, 2021 01:58 UTC INTEL CORP INTC · Entity 2799 Exercise / conversionCommon Stock 1,580 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-003591 · form4.xml · nonDerivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,765

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock.

Read SEC document
January 30, 2021 Filed Feb 3, 2021 01:58 UTC INTEL CORP INTC · Entity 2799 GrantRestricted Stock Units · Derivative 1,993 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-003591 · form4.xml · derivative · entry 3

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,993

Underlying: Common Stock · 1,993 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock.

F2 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the anniversary of the grant date (or next business date, if applicable).

F2 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the anniversary of the grant date (or next business date, if applicable).

Read SEC document
January 04, 2021 Filed Jan 4, 2021 23:14 UTC GENERAL ELECTRIC CO GE · Entity 2813 GrantDeferred Fee Phantom Stock Units · Derivative 4,210 $10.87 $45,762.70
Disclosure

SEC source: 0001231205-21-000019 · edgar.xml · derivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,239

Underlying: Common Stock · 4,210 shares

Expires not disclosed

F1 · security: Acquired at a price of $10.87 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director.

F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock.

F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director.

F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director.

Read SEC document
October 01, 2020 Filed Oct 1, 2020 23:48 UTC GENERAL ELECTRIC CO GE · Entity 2813 GrantDeferred Fee Phantom Stock Units · Derivative 7,274 $6.29 $45,753.46
Disclosure

SEC source: 0001231205-20-000184 · edgar.xml · derivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,944

Underlying: Common Stock · 7,274 shares

Expires not disclosed

F1 · security: Acquired at a price of $6.29 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director.

F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock.

F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director.

F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 13:04 UTC GENERAL ELECTRIC CO GE · Entity 2813 GrantDeferred Fee Phantom Stock Units · Derivative 6,310 $7.25 $45,747.50
Disclosure

SEC source: 0001231205-20-000105 · edgar.xml · derivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,586

Underlying: Common Stock · 6,310 shares

Expires not disclosed

F1 · security: Acquired at a price of $7.25 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director.

F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock.

F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director.

F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director.

Read SEC document
May 29, 2020 Filed Jun 2, 2020 21:01 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 2,477.7007 $80.72 $200,000.00
Disclosure

SEC source: 0001127602-20-018482 · form4.xml · derivative · entry 2

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,477.7007

Underlying: Common Stock · 2,477.7007 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 14, 2020 Filed May 18, 2020 20:48 UTC INTEL CORP INTC · Entity 2799 GrantRestricted Stock Units · Derivative 3,721 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-016963 · form4.xml · derivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,721

Underlying: Common Stock · 3,721 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock.

F1 · price: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock.

F2 · derivative.exercise_date: The reporting person elected to defer settlement of their grant of restricted stock units until the termination of their service to the Intel Corporation Board of Directors.

F3 · derivative.exercise_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2021 Annual Stockholders' Meeting.

F2 · derivative.expiration_date: The reporting person elected to defer settlement of their grant of restricted stock units until the termination of their service to the Intel Corporation Board of Directors.

F3 · derivative.expiration_date: Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2021 Annual Stockholders' Meeting.

Read SEC document
April 01, 2020 Filed Apr 2, 2020 20:39 UTC GENERAL ELECTRIC CO GE · Entity 2813 GrantDeferred Fee Phantom Stock Units · Derivative 5,850 $7.82 $45,747.00
Disclosure

SEC source: 0001231205-20-000080 · edgar.xml · derivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,198

Underlying: Common Stock · 5,850 shares

Expires not disclosed

F1 · security: Acquired at a price of $7.82 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director.

F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock.

F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director.

F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.